Importantly, MSCs secrete Dkk3 [75], and tumors containing Dkk3−/− MSCs show increased CD8+ T cell invasion and reduced M2-type macrophage infiltration, suggesting MSC-derived Dkk3 maintains the immune-suppressive capacity of the tumor microenvironment [75]. The gene discussed is CD8A; the disease is neoplasm.